Pediatric Intensive Care Unit
Conditions
Keywords
all children entering the PICU eligible for enrollment, age range: neonate to 16 years
Brief summary
While near infrared spectroscopy is an exciting technology, scientific rigor is required in order to optimize its appropriate use in the clinical arena. This study will explore the feasibility and clinical applicability of data obtained from the NIRS device. The ability to noninvasively monitor peripheral perfusion remains an area of intense research. The most widely used method is pulse oximetry. The international mandate of its use in operating rooms in the early 1990s after the publication of the Harvard minimum standards for monitoring speaks to its unquestionable utility. Its pervasive application notwithstanding, pulse oximetry merely provides a calibrated ratio of arterial and venous hemoglobin saturation. While this data is valuable, time-tested, and even may hold the promise of accurately noninvasively trending cardiac output, cellular dysmetabolism -- hallmarks of vulnerable, yet viable tissue beds -- are beyond the predictive values of currently available devices.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* neonates to 16 year olds * requiring stay in the PICU greater than 24 hours
Exclusion criteria
* anticipated PICU stay less than 24 hours * children with ALLOW NATURAL DEATH orders
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Comparison of data obtained using Near Infrared Spectroscopy (NIRS) versus traditional Pediatric Intensive Care Unit (PICU) clinical parameters | 48 hours | Upon arrival to PICU, 1 lead will be place on the forehead to monitor cerebral regional saturation (CrSO2)and 1 lead will be placed on the flank to measure somatic regional saturation (SrSO2). |
Countries
United States